Staff profile

Professor Gyan Tripathi


Head of Human Sciences Research Centre, Professor of Human Physiology

Subject

Biomedical Science and Human Biology

College

College of Science and Engineering

Department

School of Human Sciences

Research centre

Human Sciences Research Centre

ORCiD ID

0000-0001-6889-706X

Campus

Kedleston Road, Derby Campus

Email

g.tripathi@derby.ac.uk

About

I graduated with MSc in Biotechnology from the Indian Institute of Technology, Mumbai, India (1993) and completed my PhD in Biotechnology, in 1999 from National Chemical Laboratory, India on a Council of Scientific and Industrial Research Fellowship. In 1999 I moved to University of Aberdeen, and did my first postdoctoral training on, transcriptional regulation of Gcn4 in Candida albicans. Between 2002 and 2005 I worked at Babraham Institute, Cambridge and University of Cambridge on IGF signalling in murine models and stem cell biology. I was appointed as RCUK academic fellow at University of Warwick in 2005 where I developed my independent research in the area of obesity and obesity related metabolic diseases such as type 2 diabetes and cardiovascular disease and held the position of Associate Professor until 2015, later moving to University of Westminster, London as Professor of Physiology. I joined University of Derby in April 2019 where I currently hold the position of Professor of Human Physiology and Head of Human Sciences Research Centre.

Research interests

My research interest is translational and multi-disciplinary with a focus towards understanding the molecular mechanisms of obesity and obesity associated metabolic diseases such as type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD). My aim is to provide a better molecular understanding so that an improved therapy can be designed. For this research I mainly use Adipose Derived Stem Cells (ADSCs) and skeletal muscle cells, human samples as well as cellular and animal models to better understand the biological causes of insulin resistance. I work closely with clinicians, system biologists, bioinformaticians, imaging experts, chemists and scientists with expertise in “–omics” technologies (genomics, epigenomics, proteomics, transcriptomics and metabolomics). The two approaches used in my lab (listed below) are based on the prevention and discovery of new drug targets.

1. Obesity and Type 2 Diabetes

2. Epigenetic mechanisms: Nutrient-gene interactions

Recent publications

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2005

2004

2003

2002-1998

US Patents:

Qualifications

Recent conferences